ARDELYX, INC. Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised
ARDELYX, INC. (ARDX) reported Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised of $7.12 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions · last filed 2026-08-06
- ARDELYX, INC. proceeds, issuance of shares, share-based payment arrangement, including option exercised for the quarter ending 2026-06-30 was $1.68M, a 70.04% increase year-over-year.
- ARDELYX, INC. proceeds, issuance of shares, share-based payment arrangement, including option exercised for the quarter ending 2026-03-31 was $5.44M, a 267.21% increase year-over-year.
- ARDELYX, INC. proceeds, issuance of shares, share-based payment arrangement, including option exercised for the quarter ending 2025-12-31 was $557.00K, a 8.99% decline year-over-year.
- ARDELYX, INC. proceeds, issuance of shares, share-based payment arrangement, including option exercised for the quarter ending 2025-09-30 was $2.81M, a 4.34% increase year-over-year.
- ARDELYX, INC. proceeds, issuance of shares, share-based payment arrangement, including option exercised for fiscal 2025 was $5.84M, a 28.23% decline from fiscal 2024.
- ARDELYX, INC. proceeds, issuance of shares, share-based payment arrangement, including option exercised for fiscal 2024 was $8.14M, a 593.78% increase from fiscal 2023.
- ARDELYX, INC. proceeds, issuance of shares, share-based payment arrangement, including option exercised for fiscal 2023 was $1.17M, a 480.69% increase from fiscal 2022.
- ARDELYX, INC. proceeds, issuance of shares, share-based payment arrangement, including option exercised for fiscal 2022 was $202.00K, a 85.60% decline from fiscal 2021.
| Period end | Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised 3 month | Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised 6 month | Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised 6 month as first filed | Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised 9 month | Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised 9 month as first filed | Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1.68M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $7.12M 10-Q · filed 2026-08-06 | $7.68M derived: sum of 3 quarters · filed 2026-08-06 | $10.49M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2026-03-31 | $5.44M 10-Q · filed 2026-04-30 | $6.00M derived: sum of 2 quarters · filed 2026-04-30 | $8.81M derived: sum of 3 quarters · filed 2026-04-30 | $9.80M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-12-31 | $557.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $3.37M derived: sum of 2 quarters · filed 2026-02-19 | $4.36M derived: sum of 3 quarters · filed 2026-08-06 | $5.84M 10-K · filed 2026-02-19 | ||
| 2025-09-30 | $2.81M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $3.80M derived: sum of 2 quarters · filed 2026-08-06 | $5.28M 10-Q · filed 2025-10-30 | $5.90M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-06-30 | $988.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $2.47M 10-Q · filed 2026-08-06 | $3.08M derived: sum of 3 quarters · filed 2026-08-06 | $5.78M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-03-31 | $1.48M 10-Q · filed 2026-04-30 | $2.09M derived: sum of 2 quarters · filed 2026-04-30 | $4.79M derived: sum of 3 quarters · filed 2026-04-30 | $6.40M derived: sum of 4 quarters · filed 2026-04-30 | ||
| 2024-12-31 | $612.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $3.31M derived: sum of 2 quarters · filed 2026-02-19 | $4.92M derived: sum of 3 quarters · filed 2026-02-19 | $8.14M 10-K · filed 2026-02-19 | ||
| 2024-09-30 | $2.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $4.30M derived: sum of 2 quarters · filed 2025-10-30 | $7.53M 10-Q · filed 2025-10-30 | $7.64M derived: sum of 4 quarters · filed 2026-02-19 | ||
| 2024-06-30 | $1.61M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-04 | $4.83M 10-Q · filed 2025-08-04 | $4.94M derived: sum of 3 quarters · filed 2026-02-19 | $5.65M derived: sum of 4 quarters · filed 2026-02-19 | ||
| 2024-03-31 | $3.22M 10-Q · filed 2025-05-01 | $3.33M derived: sum of 2 quarters · filed 2026-02-19 | $4.04M derived: sum of 3 quarters · filed 2026-02-19 | $4.19M derived: sum of 4 quarters · filed 2026-02-19 | ||
| 2023-12-31 | $114.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $824.00K derived: sum of 2 quarters · filed 2026-02-19 | $973.00K derived: sum of 3 quarters · filed 2026-02-19 | $1.17M 10-K · filed 2026-02-19 | ||
| 2023-09-30 | $710.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | $859.00K derived: sum of 2 quarters · filed 2024-10-31 | $1.06M 10-Q · filed 2024-10-31 | $1.07M derived: sum of 4 quarters · filed 2025-02-20 | ||
| 2023-06-30 | $149.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $349.00K 10-Q · filed 2024-08-01 | $356.00K derived: sum of 3 quarters · filed 2025-02-20 | $468.00K derived: sum of 4 quarters · filed 2025-02-20 | ||
| 2023-03-31 | $200.00K 10-Q · filed 2024-05-02 | $207.00K derived: sum of 2 quarters · filed 2025-02-20 | $319.00K derived: sum of 3 quarters · filed 2025-02-20 | $319.00K derived: sum of 4 quarters · filed 2025-02-20 | ||
| 2022-12-31 | $7.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20 | $119.00K derived: sum of 2 quarters · filed 2025-02-20 | $119.00K derived: sum of 3 quarters · filed 2025-02-20 | $202.00K 10-K · filed 2025-02-20 | ||
| 2022-09-30 | $112.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-31 | $112.00K derived: sum of 2 quarters · filed 2023-10-31 | $195.00K 10-Q · filed 2023-10-31 | $195.00K derived: sum of 4 quarters · filed 2024-02-22 | ||
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | $83.00K 10-Q · filed 2023-08-02 | $83.00K derived: sum of 3 quarters · filed 2024-02-22 | $445.00K derived: sum of 4 quarters · filed 2024-02-22 | ||
| 2022-03-31 | $83.00K 10-Q · filed 2023-05-03 | $83.00K derived: sum of 2 quarters · filed 2024-02-22 | $445.00K derived: sum of 3 quarters · filed 2024-02-22 | $988.00K derived: sum of 4 quarters · filed 2024-02-22 | ||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $362.00K derived: sum of 2 quarters · filed 2024-02-22 | $905.00K derived: sum of 3 quarters · filed 2024-02-22 | $1.40M 10-K · filed 2024-02-22 | ||
| 2021-09-30 | $362.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $905.00K derived: sum of 2 quarters · filed 2022-11-03 | $1.40M 10-Q · filed 2022-11-03 | $1.66M derived: sum of 4 quarters · filed 2023-03-02 | ||
| 2021-06-30 | $543.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $1.04M 10-Q · filed 2022-08-04 | $1.30M derived: sum of 3 quarters · filed 2023-03-02 | $2.10M derived: sum of 4 quarters · filed 2023-03-02 | ||
| 2021-03-31 | $498.00K 10-Q · filed 2022-05-05 | $759.00K derived: sum of 2 quarters · filed 2023-03-02 | $1.56M derived: sum of 3 quarters · filed 2023-03-02 | $1.76M derived: sum of 4 quarters · filed 2023-03-02 | ||
| 2020-12-31 | $261.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | $1.06M derived: sum of 2 quarters · filed 2023-03-02 | $1.26M derived: sum of 3 quarters · filed 2023-03-02 | $1.85M 10-K · filed 2023-03-02 | ||
| 2020-09-30 | $798.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $1.00M derived: sum of 2 quarters · filed 2021-11-12 | $1.59M 10-Q · filed 2021-11-12 | $1.75M derived: sum of 4 quarters · filed 2022-02-28 | ||
| 2020-06-30 | $204.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-13 | $795.00K 10-Q · filed 2021-08-13 | $951.00K derived: sum of 3 quarters · filed 2022-02-28 | |||
| 2020-03-31 | $591.00K 10-Q · filed 2021-05-06 | $747.00K derived: sum of 2 quarters · filed 2022-02-28 | ||||
| 2019-12-31 | $156.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $574.00K 10-K · filed 2022-02-28 | ||||
| 2019-09-30 | $418.00K 10-Q · filed 2020-11-05 | |||||
| 2019-03-31 | $198.00K 10-Q · filed 2019-05-07 | $197.00K derived: sum of 2 quarters · filed 2021-03-08 | $388.00K derived: sum of 3 quarters · filed 2021-03-08 | $388.00K derived: sum of 4 quarters · filed 2021-03-08 | ||
| 2018-12-31 | -$1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-08 | $190.00K derived: sum of 2 quarters · filed 2021-03-08 | $190.00K derived: sum of 3 quarters · filed 2021-03-08 | $491.00K 10-K · filed 2021-03-08 | ||
| 2018-09-30 | $191.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $191.00K derived: sum of 2 quarters · filed 2018-11-07 | $492.00K 10-Q · filed 2018-11-07 | $502.00K derived: sum of 4 quarters · filed 2019-05-07 | ||
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $301.00K 10-Q · filed 2018-08-07 | $311.00K derived: sum of 3 quarters · filed 2019-05-07 | $562.00K derived: sum of 4 quarters · filed 2019-05-07 | ||
| 2018-03-31 | $301.00K 10-Q · filed 2019-05-07 | $311.00K derived: sum of 2 quarters · filed 2019-05-07 | $562.00K derived: sum of 3 quarters · filed 2019-05-07 | $578.00K derived: sum of 4 quarters · filed 2019-05-07 | ||
| 2017-12-31 | $10.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-06 | $261.00K derived: sum of 2 quarters · filed 2019-03-06 | $277.00K derived: sum of 3 quarters · filed 2019-03-06 | $685.00K 10-K · filed 2019-03-06 | ||
| 2017-09-30 | $251.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $267.00K derived: sum of 2 quarters · filed 2018-11-07 | $675.00K 10-Q · filed 2018-11-07 | $890.00K derived: sum of 4 quarters · filed 2019-03-06 | ||
| 2017-06-30 | $16.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $424.00K 10-Q · filed 2018-08-07 | $626.00K 10-Q · filed 2017-08-09 | $639.00K derived: sum of 3 quarters · filed 2019-03-06 | $583.00K derived: sum of 4 quarters · filed 2019-03-06 | |
| 2017-03-31 | $408.00K 10-Q · filed 2018-05-08 | $623.00K derived: sum of 2 quarters · filed 2019-03-06 | $567.00K derived: sum of 3 quarters · filed 2019-03-06 | $755.00K derived: sum of 4 quarters · filed 2019-03-06 | ||
| 2016-12-31 | $215.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-06 | $159.00K derived: sum of 2 quarters · filed 2019-03-06 | $347.00K derived: sum of 3 quarters · filed 2019-03-06 | $631.00K 10-K · filed 2019-03-06 | ||
| 2016-09-30 | -$56.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $132.00K derived: sum of 2 quarters · filed 2017-11-07 | $416.00K 10-Q · filed 2017-11-07 | $603.00K 10-Q · filed 2016-11-07 | $429.00K derived: sum of 4 quarters · filed 2018-03-14 | |
| 2016-06-30 | $188.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $472.00K 10-Q · filed 2017-08-09 | $485.00K derived: sum of 3 quarters · filed 2018-03-14 | |||
| 2016-03-31 | $284.00K 10-Q · filed 2017-05-05 | $297.00K derived: sum of 2 quarters · filed 2018-03-14 | ||||
| 2015-12-31 | $13.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14 | $659.00K 10-K · filed 2018-03-14 | ||||
| 2015-09-30 | $646.00K 10-Q · filed 2016-11-07 | |||||
| 2014-12-31 | $71.00K 10-K · filed 2017-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |